Emergent BioSolutions facility
GPTKB entity
Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biopharmaceutical manufacturing facility
|
| gptkbp:capacity |
large-scale vaccine production
|
| gptkbp:employs |
biomanufacturing staff
|
| gptkbp:explores |
gptkb:U.S._Food_and_Drug_Administration
|
| https://www.w3.org/2000/01/rdf-schema#label |
Emergent BioSolutions facility
|
| gptkbp:locatedIn |
gptkb:Baltimore,_Maryland
|
| gptkbp:ownedBy |
gptkb:Emergent_BioSolutions
|
| gptkbp:produced |
gptkb:COVID-19_vaccines
gptkb:AstraZeneca_COVID-19_vaccine gptkb:Johnson_&_Johnson_COVID-19_vaccine |
| gptkbp:subjectOf |
FDA inspections
vaccine contamination incident |
| gptkbp:suspendedProduction |
2021
|
| gptkbp:bfsParent |
gptkb:COVID-19_vaccine_manufacturing_contamination_(2021)
|
| gptkbp:bfsLayer |
6
|